Literature DB >> 20833834

Responses against a subdominant CD8+ T cell epitope protect against immunopathology caused by a dominant epitope.

Tracy J Ruckwardt1, Cindy Luongo, Allison M W Malloy, Jie Liu, Man Chen, Peter L Collins, Barney S Graham.   

Abstract

CD8(+) T cell responses are critical for the control of virus infections. Following infection, epitope-specific responses establish an unpredictable but reproducible pattern of dominance that is dictated by a large number of both positive and negative factors. Immunodomination, or diminution of subdominant epitope-specific responses by dominant epitopes, can play a substantial role in the establishment of epitope hierarchy. To determine the role of a dominant (K(d)M2(82-90)) and a subdominant (D(b)M(187-195)) epitope of respiratory syncytial virus in viral control and immunodomination, MHC-binding anchor residues in the two epitopes were mutated individually in recombinant infectious viruses, greatly reducing or deleting the epitope-specific CD8(+) T cell responses. Neither mutation negatively affected viral clearance in mice, and compensation by the unmutated epitope was seen in both cases, whereas compensation by five other subdominant epitopes was minimal. Mutation of the dominant K(d)M2(82-90) response resulted in effective viral clearance by the subdominant epitope with less illness, whereas mutation of the subdominant D(b)M(187-195) response resulted in overcompensation of the already dominant K(d)M2(82-90) epitope, and increased severity of illness. Increased illness was associated with poor functionality of the abundant population of CD8(+) T cells specific to the dominant K(d)M2(82-90) epitope, as measured by the percentage and magnitude of IFN-γ production. These data demonstrate efficient viral clearance, and a protective effect of subdominant CD8(+) T cell responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20833834      PMCID: PMC4144756          DOI: 10.4049/jimmunol.1001606

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses.

Authors:  W Chen; L C Antón; J R Bennink; J W Yewdell
Journal:  Immunity       Date:  2000-01       Impact factor: 31.745

Review 2.  Epitope dominance, competition and T cell affinity maturation.

Authors:  Ross M Kedl; John W Kappler; Philippa Marrack
Journal:  Curr Opin Immunol       Date:  2003-02       Impact factor: 7.486

3.  Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus.

Authors:  Shisong Jiang; Nicola J Borthwick; Paul Morrison; George F Gao; Michael W Steward
Journal:  J Gen Virol       Date:  2002-02       Impact factor: 3.891

4.  Silencing an immunodominant epitope of hepatitis B surface antigen reveals an alternative repertoire of CD8 T cell epitopes of this viral antigen.

Authors:  Andreas Wieland; Petra Riedl; Jörg Reimann; Reinhold Schirmbeck
Journal:  Vaccine       Date:  2009-10-08       Impact factor: 3.641

5.  Granulocyte-macrophage colony-stimulating factor expressed by recombinant respiratory syncytial virus attenuates viral replication and increases the level of pulmonary antigen-presenting cells.

Authors:  A Bukreyev; I M Belyakov; J A Berzofsky; B R Murphy; P L Collins
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

6.  Visualization and characterization of respiratory syncytial virus F-specific CD8(+) T cells during experimental virus infection.

Authors:  J Chang; A Srikiatkhachorn; T J Braciale
Journal:  J Immunol       Date:  2001-10-15       Impact factor: 5.422

7.  Respiratory syncytial virus infection suppresses lung CD8+ T-cell effector activity and peripheral CD8+ T-cell memory in the respiratory tract.

Authors:  Jun Chang; Thomas J Braciale
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

8.  Immunodominance in virus-induced CD8(+) T-cell responses is dramatically modified by DNA immunization and is regulated by gamma interferon.

Authors:  Fernando Rodriguez; Stephanie Harkins; Mark K Slifka; J Lindsay Whitton
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

9.  A systemic neutrophil response precedes robust CD8(+) T-cell activation during natural respiratory syncytial virus infection in infants.

Authors:  Michaël V Lukens; Alma C van de Pol; Frank E J Coenjaerts; Nicolaas J G Jansen; Vera M Kamp; Jan L L Kimpen; John W A Rossen; Laurien H Ulfman; Carline E A Tacke; Marco C Viveen; Leo Koenderman; Tom F W Wolfs; Grada M van Bleek
Journal:  J Virol       Date:  2009-12-16       Impact factor: 5.103

10.  Protection and compensation in the influenza virus-specific CD8+ T cell response.

Authors:  Richard J Webby; Samita Andreansky; John Stambas; Jerold E Rehg; Robert G Webster; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

View more
  34 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  Shared αβ TCR Usage in Lungs of Sarcoidosis Patients with Löfgren's Syndrome.

Authors:  Angela M Mitchell; Ylva Kaiser; Michael T Falta; Daniel J Munson; Laurie G Landry; Anders Eklund; Maki Nakayama; Jill E Slansky; Johan Grunewald; Andrew P Fontenot
Journal:  J Immunol       Date:  2017-08-21       Impact factor: 5.422

3.  Identification of Novel Respiratory Syncytial Virus CD4+ and CD8+ T Cell Epitopes in C57BL/6 Mice.

Authors:  Megan E Schmidt; Steven M Varga
Journal:  Immunohorizons       Date:  2019-01-14

4.  Live attenuated influenza vaccine viral vector induces functional cytotoxic T-cell immune response against foreign CD8+ T-cell epitopes inserted into NA and NS1 genes using the 2A self-cleavage site.

Authors:  Tatiana Kotomina; Daniil Korenkov; Victoria Matyushenko; Polina Prokopenko; Larisa Rudenko; Irina Isakova-Sivak
Journal:  Hum Vaccin Immunother       Date:  2018-08-29       Impact factor: 3.452

5.  Identification of multiple public TCR repertoires in chronic beryllium disease.

Authors:  Natalie A Bowerman; Michael T Falta; Douglas G Mack; Fabian Wehrmann; Frances Crawford; Margaret M Mroz; Lisa A Maier; John W Kappler; Andrew P Fontenot
Journal:  J Immunol       Date:  2014-04-09       Impact factor: 5.422

Review 6.  Beryllium-Induced Hypersensitivity: Genetic Susceptibility and Neoantigen Generation.

Authors:  Andrew P Fontenot; Michael T Falta; John W Kappler; Shaodong Dai; Amy S McKee
Journal:  J Immunol       Date:  2016-01-01       Impact factor: 5.422

7.  T Cell receptor clonotype influences epitope hierarchy in the CD8+ T cell response to respiratory syncytial virus infection.

Authors:  Padma Billam; Kathryn L Bonaparte; Jie Liu; Tracy J Ruckwardt; Man Chen; Alex B Ryder; Rui Wang; Pradyot Dash; Paul G Thomas; Barney S Graham
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

8.  Vaccination with synthetic constructs expressing cytomegalovirus immunogens is highly T cell immunogenic in mice.

Authors:  Devon J Shedlock; Kendra T Talbott; Stephan J Wu; Christine M Wilson; Karuppiah Muthumani; Jean D Boyer; Niranjan Y Sardesai; Sita Awasthi; David B Weiner
Journal:  Hum Vaccin Immunother       Date:  2012-11-01       Impact factor: 3.452

9.  Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola.

Authors:  Devon J Shedlock; Jenna Aviles; Kendra T Talbott; Gary Wong; Stephan J Wu; Daniel O Villarreal; Devin Jf Myles; Maria A Croyle; Jian Yan; Gary P Kobinger; David B Weiner
Journal:  Mol Ther       Date:  2013-05-14       Impact factor: 11.454

10.  CD8(+) T cells from mice transnuclear for a TCR that recognizes a single H-2K(b)-restricted MHV68 epitope derived from gB-ORF8 help control infection.

Authors:  Sharvan Sehrawat; Oktay Kirak; Paul-Albert Koenig; Marisa K Isaacson; Sofia Marques; Gunes Bozkurt; J Pedro Simas; Rudolph Jaenisch; Hidde L Ploegh
Journal:  Cell Rep       Date:  2012-04-26       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.